"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments, and email. This allows you to still get great care while helping to address the community spread of COVID-19. If you’re concerned about your specific health condition, call 1-833-KP4CARE (1-833-574-2273) (TTY 711) to talk to a licensed care provider 24/7. For answers to your general questions about COVID-19, call our new information line for Kaiser Permanente members at 1-877-813-7297."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
59
SWOG Cancer Research Network
30
Alliance for Clinical Trials in Oncology
7
NSABP Foundation Inc
6
ECOG-ACRIN Cancer Research Group
5
NRG Oncology
3
Wake Forest University Health Sciences
3
Gilead Sciences
2
Children's Oncology Group
1
Eli Lilly and Company
1
National Heart, Lung, and Blood Institute (NHLBI)
1
Clinical Trials at Kaiser Permanente West Los Angeles
During the past decade, Kaiser Permanente West Los Angeles conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 46 clinical trials were completed, i.e. on
average, 64.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 28 clinical trials were completed. i.e. 215.4%
of trials that started reached the finish line.
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
2008-04-15
Completed
130
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kaiser Permanente West Los Angeles" #1 sponsor was "National Cancer Institute (NCI)" with 59 trials, followed by "SWOG Cancer Research Network" with 30 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 6 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente West Los Angeles"
#1 collaborator was "National Cancer Institute (NCI)" with 54 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were
collaborators in the rest 21 trials.
Clinical Trials Conditions at Kaiser Permanente West Los Angeles
According to Clinical.Site data, the most researched conditions in "Kaiser Permanente West Los Angeles" are
"Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IVA Lung Cancer AJCC v8" (7 trials) and "Stage IVB Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Kaiser Permanente West Los Angeles" in a lesser frequency.
Clinical Trials Intervention Types at Kaiser Permanente West Los Angeles
Most popular intervention types in "Kaiser Permanente West Los Angeles" are "Drug" (90 trials), "Other" (78 trials), "Biological" (54 trials), "Procedure" (29 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "Quality-of-Life Assessment" (27 trials), "Biospecimen Collection" (18 trials), "Computed Tomography" (18 trials) and "Questionnaire Administration" (18 trials). Other intervention names were less common.
Clinical Trials Genders at Kaiser Permanente West Los Angeles
The vast majority of trials in "Kaiser Permanente West Los Angeles" are
97 trials for "All" genders, 18 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Kaiser Permanente West Los Angeles
Currently, there are NaN active trials in "Kaiser Permanente West Los Angeles".
undefined are not yet recruiting,
24 are recruiting,
56 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 29 completed trials in Kaiser Permanente West Los Angeles,
1 suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Kaiser Permanente West Los Angeles, 0 "Phase 1"
clinical trials were conducted, 51 "Phase 2" clinical
trials and 65 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".